Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 224

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 224
---
 purchased in the Offering that are not exercisable until December 23, 2025. |

| (25) | The reported securities are held directly by the Lee M. Barlas and Irini Barlas Living Trust. Lee Barlas, as trustee, has sole voting and investment power and may be deemed the beneficial owner thereunder. Lee Barlas disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (26) | Excludes, for beneficial ownership purposes, 188,680 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (27) | Excludes, for beneficial ownership purposes, 94,340 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (28) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (29) | Excludes, for beneficial ownership purposes, 150,944 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (30) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (31) | Excludes, for beneficial ownership purposes, 94,340 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (32) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (33) | The reported securities are held directly by 3i, LP (“3i”) and may be deemed to be beneficially owned by Maier Tarlow, Manager of 3i. Maier Tarlow disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (34) | Excludes, for beneficial ownership purposes, 188,680 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (35) | The reported securities are held directly by Alta Partners, LLC (“Alta Partners”) and may be deemed to be